Therapeutic Virtual Reality: Helps Reduce Anxiety and Pain During Bronchial Fibroscopies in Lung Transplant Patients. (REVDOU)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04731792 |
Recruitment Status :
Recruiting
First Posted : February 1, 2021
Last Update Posted : February 1, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Marie Lannelongue Hospital is a hospital specialized in lung transplantation. Lung transplant patients require regular check-ups by bronchial fibroscopy. This examination is known to be anxious, stressful and sometimes painful. These patients take many medications (immunosuppressants, antibiotics....) that may interact with analgesic or anxiolytic drugs.
The objective is to propose to HML lung transplant patients a virtual reality solution containing visual and auditory 3D experiences to fight against anxiety and pain during repetitive and anxiogenic examinations such as bronchial fibroscopies.
Translated with www.DeepL.com/Translator (free version)
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Anxiety Stress Pain Bronchial Fibroscopy Pulmonary Transplantation | Other: Virtual Reality | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 152 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | Therapeutic Virtual Reality: Helps Reduce Anxiety and Pain During Bronchial Fibroscopies in Lung Transplant Patients. |
Actual Study Start Date : | January 14, 2021 |
Estimated Primary Completion Date : | January 14, 2024 |
Estimated Study Completion Date : | February 14, 2024 |

Arm | Intervention/treatment |
---|---|
Experimental: Virtual Reality group |
Other: Virtual Reality
a bronchial fibroscopy with a virtual reality helmet |
No Intervention: control group |
- Visual Analogic Scale (VAS) score from 0 (no anxiety) to 10 (terrified). [ Time Frame: 1 day ]
- Evaluation of pain by a score on a numerical scale (EN) from 0 (no pain) to 10 (unbearable pain) [ Time Frame: 1 day ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patient with a lung or cardio-pulmonary transplant
- Adults (age > 18 years old)
- Patient who give their informed consent for the protocol
- Patient requiring a bronchial fibroscopy and having already had at least one - bronchial fibroscopy without virtual reality
Exclusion Criteria:
- children

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04731792
Contact: Cécile DEGOULET | 01 40 94 25 98 | c.degoulet@ghpsj.fr |
France | |
Centre Chirurgical Marie Lannelongue | Recruiting |
Le Plessis Robinson, France, 92350 | |
Contact: cecile Degoulet 01.40.94.25.98 c.degoulet@ghpsj.fr |
Responsible Party: | Centre Chirurgical Marie Lannelongue |
ClinicalTrials.gov Identifier: | NCT04731792 |
Other Study ID Numbers: |
2020-A00658-31 |
First Posted: | February 1, 2021 Key Record Dates |
Last Update Posted: | February 1, 2021 |
Last Verified: | January 2021 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Anxiety Disorders Mental Disorders |